Form 8-K - Current report:
SEC Accession No. 0001564590-16-014298
Filing Date
2016-03-09
Accepted
2016-03-09 16:13:42
Documents
2
Period of Report
2016-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ogxi-8k_20160309.htm 8-K 29691
2 EX-99.1 ogxi-ex991_6.htm EX-99.1 249551
  Complete submission text file 0001564590-16-014298.txt   280510
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 161494737
SIC: 2835 In Vitro & In Vivo Diagnostic Substances